“Find some tumor-specific receptors and attach the ligands to the nanotubes.”
As is the case with other attempts at molecular targetting, they’re apparently seeing residual uptake where they’d prefer not to. For this method to be effective they’ll need to develop a targetting and delivery system flexible enough to account for the wide disparities between one cancer and another.